Aganitha
Aganitha accelerates drug discovery and development with AI and Cloud powered in silico solutions for:
Multi-omics (GWAS, scRNA-seq, Proteomics, …) studies in disease research
De novo design, optimization and development of small molecule (SMOL), antibodies, gene & RNA therapies
Process R&D for synthesis of small molecules and biologicals
AI-Enabled Services:
Research services that use machine learning (ML) algorithms
Research services that use large language models (LLM)
Research services that use natural language processing (NLP)
Data services that use ML, LLMs or NLP
Utilize Aganitha AI technologies in the following spaces:
Biology, including target discovery, imaging and HTS
Chemistry, including analytical chemistry, manufacturing & medicinal chemistry
Pharmacology, including in vitro and in vivo disease models
Drug Metabolism, including pharmacokinetics and ADME
Data, including data transfer, analysis and storage